Table 4.
Multivariable analysis for good clinical outcome at three months after index stroke with following dependent variables.
| Variables | *Odds ratio (95% confidence interval) |
p Value |
|---|---|---|
| Sex, male | 0.67 (0.21–2.10) | .493 |
| Age, years | 0.97 (0.92–1.01) | .173 |
| Prior stroke statin use | 13.05 (2.08–81.88) | .006 |
| NIHSS | 0.55 (0.44–0.69) | <.001 |
| Cerebral atherosclerosis | 2.06 (0.60–7.08) | .250 |
| Stroke subtype | ||
| Cardioembolism | 1.21 (0.29–5.11) | .792 |
| Large artery atherosclerosis | 1.43 (0.38–5.40) | .602 |
| Small vessel occlusion | References | |
| Plasma Klotho (per 100 unit) | 2.42 (1.45–4.04) | <.001 |
| Fibroblast growth factor-23 (per 100 unit) | 0.88 (0.79–0.98) | .025 |
| White blood cell count | 0.98 (0.80–1.20) | .831 |
| C-reactive protein | 0.93 (0.76–1.13) | .454 |
Data are shown as odds ratio (95% confidence interval).
NIHSS: National Institutes of Health Stroke Scale.
*Adjusted for sex, age, prior stroke statin use, NIHSS, cerebral atherosclerosis, stroke subtype, fibroblast growth factor-23, white blood cell count and C-reactive protein.